EXACT Sciences Stock Price (NASDAQ:EXAS)

Add to My Stocks
$39.65 $2.32 (6.21%) EXAS stock closing price Jul 26, 2017 (Closing)
Prev Close* : $37.33
Market Cap:
$4.45B
Day Low: $39.41
52 Week Low: $13.05
Open: $40.07
Volume: 7789030
Day High: $42.18
52 Week High: $42.18
Dividend:
N/A

Latest Stock Market News

Latest Articles

EXACT Sciences News - From Partners

New Strong Buy Stocks for July 19th   by Zacks on Jul 19, 2017
New Strong Buy Stocks for July 17th   by Zacks on Jul 17, 2017

EXAS Stockcharts

View EXAS PE ratio, PS ratio stocks charts and compare with peers.
EXAS Chart
Note: Compare EXACT Sciences stock price history with the index and industry peers.

EXACT Sciences Valuation

PS ratio (
price to sales ratio
)
26.42
PB ratio (
price to book ratio
)
12.45

EXACT Sciences Financial Ratios

Asset Turnover
0.53
Receivables Turnover
14.56
Debt to Equity
0.02

EXAS Industry Peers

Company Price Change (%)
Kite Pharma (KITE)111.240.72 (0.65%)
Dyax (DYAX)38.410 (0%)
Quest Diagnostics (DGX)108.220.04 (0.04%)
Cancer Genetics (CGIX)3.750 (0%)
Invitae Corp (NVTA)9.370.02 (0.21%)
Ironwood Pharma (IRWD)17.10.06 (0.35%)
Neogenomics (NEO)9.40.15 (1.62%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
EXACT Sciences (EXAS)39.652.32 (6.21%)
Dynavax Technologies (DVAX)10.40.5 (5.05%)
MannKind (MNKD)1.320.06 (4.76%)
BioDelivery Sciences (BDSI)3.50.15 (4.48%)
Biogen Inc (BIIB)295.6112.65 (4.47%)
Paratek Pharma (PRTK)21.450.85 (4.13%)
Vital Therapies (VTL)2.750.1 (3.77%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 27, 2017
CompanyPriceChange (%)
Integra LifeSciences (IART)49.745.88 (10.57%)
Idera Pharma (IDRA)1.940.12 (5.83%)
Kamada (KMDA)5.150.25 (4.63%)
Peregrine Pharma (PPHM)4.30.2 (4.44%)
Fate Therapeutics (FATE)2.830.11 (3.74%)
Compugen (CGEN)3.90.15 (3.7%)
Trevena (TRVN)2.720.1 (3.55%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 27, 2017

EXACT Sciences Corporation Stock News - Partner Headlines

EXACT Sciences Financial Statements

income statement20162015201420132012
Net Sales Or Revenues99.37M39.43M1.79M4.14M4.14M
Net Income-167.21M-157.8M-100.04M-46.51M-52.42M
Total Operating Expense223.19M174M98M50.89M56.78M
view EXACT Sciences Corporation income statement
balance sheet20162015201420132012
Total Assets377.04M364.29M311.62M146.62M112.11M
Total Liabilities41.74M37.44M22.64M11.31M13.52M
Shareholders Equity335.29M326.85M288.98M135.31M98.59M
view EXACT Sciences Corporation balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities1.76M-1.29M3.79M-1.19M4.24M
Net Cash From (Used By) Operating Activities-130.06M-134.01M-80.91M-39.29M-44.15M
Increase (Decrease) In Prop Plant And Equipment-14.85M-20.08M-12.53M-9.28M-0.68M
view EXACT Sciences Corporation cashflow statement

EXACT Sciences Stock Message Board

An investor needs to spend 39.65 to buy EXAS stock, as the closing EXACT Sciences stock price is 39.65. Stock price or share price can be used to find the total market value of a company. EXACT Sciences market cap stands at 4.45B as of 26 Jul, 2017. A value investor must look at the fundamentals of a stock, and perform EXACT Sciences valuation, even though in the short-term sentiment and current breaking news might affect EXACT Sciences stock price.

For recognizing and analyzing the real performance of EXACT Sciences stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 7789030 on the last trading day, as is evident from EXACT Sciences stock chart, and EXAS stock quote data. To check the historical stock price movement, all time high, and all time low of EXAS, view EXACT Sciences stock price history.